James A Geraghty is of Fulcrum Therapeutics, Inc.. Currently has a direct ownership of 90,714 shares of FULC, which is worth approximately $394,605. The most recent transaction as insider was on Jun 28, 2021, when has been sold 10,000 shares (Common Stock) at a price of $9.16 per share, resulting in proceeds of $91,600. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 90.7K
0% 3M change
0% 12M change
Total Value Held $394,605

JAMES A GERAGHTY Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 28 2021
BUY
Open market or private purchase
$91,600 $9.16 p/Share
10,000 Added 9.93%
90,714 Common Stock

Also insider at

VYGR
Voyager Therapeutics, Inc. Healthcare
PIRS
PIERIS PHARMACEUTICALS, INC. Healthcare
ORTX
Orchard Therapeutics plc Healthcare
IDRA
IDERA PHARMACEUTICALS, INC. Healthcare
JAG

James A Geraghty

Exton, PA

Track Institutional and Insider Activities on FULC

Follow Fulcrum Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FULC shares.

Notify only if

Insider Trading

Get notified when an Fulcrum Therapeutics, Inc. insider buys or sells FULC shares.

Notify only if

News

Receive news related to Fulcrum Therapeutics, Inc.

Track Activities on FULC